Non-Clinical Models for Neurodegenerative Diseases: Therapeutic Approach and Drug Validation in Animal Models

Area of Science:

• Biomedical Sciences
• Neuroscience
• Gerontology

Background:

• Cuba's aging population (19.8% over 60 in 2016) necessitates focus on age-associated diseases.
• Neurodegenerative diseases are a growing public health concern, requiring advanced research.
• The Cuban biomedical community is actively pursuing research to address these challenges.

Purpose of the Study:

• To review the state-of-the-art in non-clinical models for neurodegenerative diseases.
• To foster collaboration and identify unifying objectives among international researchers.
• To explore new biotechnological products for diagnosis, therapy, and neuroprotection.

Main Methods:

• International congress on non-clinical models for neurodegenerative diseases.
• Review of current research trends in neurodegeneration.
• Discussion on the ethical and rational use of laboratory animals in research.

Main Results:

• Identified key areas for advancement in neurodegenerative disease research.
• Highlighted the importance of international collaboration and knowledge exchange.
• Emphasized the role of non-clinical models in developing diagnostic and therapeutic strategies.

Conclusions:

• Continued research and international collaboration are vital for combating neurodegenerative diseases.
• Development of novel biotechnological products is crucial for improved patient outcomes.
• Ethical and rational use of animal models remains essential for scientific progress in this field.